Analysis of prognostic factors of diffuse midline glioma.
Time of Update: 2020-09-07
analysis of patients with diffuse mid-line glioma H3K27M mutations found that in patients with H3K27M mutations, PDGFRA amplification (P=0.010), 17p deficiency (P=0.008) and complex chromosome structures (P=0.044) were significantly associated with shorter total survival (Figure 1).
Gene diffusion methods: How to measure and limit the environmental risks of gene-driven strategies.
Time of Update: 2020-08-28
at the same time, if the genes introduced have uexpected consequences, researchers may be able to reverse the gene drive by introducing more "crazy" and undecided genes that outnate the former in number.
FDA awards Paxalisib the title of rare pediatric disease therapy (RPDD) for the treatment of diffuse endogenic bridge glioma
Time of Update: 2020-08-25
RPDD granted, Kazia is eligible for the Rare Pediatric Disease Priority Examination Certificate (PRV) if Paxalisib is approved for treatment of DIPG.
2 cases of acute diffuse brain swelling.
Time of Update: 2020-08-24
2 h, the patient is irritable, the left pupil is scattered large, the light reflection disappears, review the brain CT found that the left armatum pillow epidural hematoma, the middle line is right.
Gastric Cancer: Leukin-17A, derived from fat cells, promotes fibrosis of stomach cancer through peritoneal diffusion.
Time of Update: 2020-08-20
therefore, in this study, we explored which cells are the main source of IL-17A and the relationship between tissue fibrosis and IL-17A in the peritoneal diffusion of stomach cancer.
For the first time, JCC-coupling constant measurement of protein across Van der Waal forces was achieved.
Time of Update: 2020-08-10
Protein is an important component of life and life activities, there are many non-covalent interactions in protein work together to stabilize protein structure and realize the function of protein. , Vanderwaer's role is a force that can
The FDA approved the Monjuvi (tafasitamab-cxix) joint lying to treat relapse diffuse large B-cell lymphoma.
Time of Update: 2020-08-06
Pharmaceutical companies MorphoSys and Incyte announced today that the U.S. Food and Drug Administration (FDA) has approved a combination of Monjuvi ® (tafasitamab-cxix) to treat patients with recurrent or refractable diffuse large B-cell lymphoma
Acta Neuropathologica: A case of COVID-19 in young people H3K27M mutant diffuse midline glial
Time of Update: 2020-07-28
Little is known about the effects of new coronavirus diseases on tumor biology associated with high coagulation and cerebrovascular accidents. Malignant tumors are closely related to high coagulation status, which varies according to age and tumor
Lymphoma Targets Immunotherapy! Roche CD79b target drug Polivy Japan applies for listing for diffuse large B-cell lymphoma (DLBCL)
Time of Update: 2020-07-15
, July 04, 2020 / Biogu BIOON/ -- Chugai, a Japanese pharmaceutical company controlled by Roche, has recently submitted a new drug application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) for the treatment
Clin Cancer Research: Tazemetostat (EPZ-6438) Joint R-CHOP treatment of diffuse large B cell lymphoma
Time of Update: 2020-07-13
method: This is a Phase Ib clinical trial that evaluates the safety of EPZ-6438 joint R-CHOP for newly diagnosed diffuse large B-cell lymphoma sepsis aged 60-80 years, and identifies the recommended dose (RP2D) for EPZ-6438 Phase II.
Arthritis Rheumatol: Lung function check in patients with interstitial lung disease in patients with early diffuse skin SSc
Time of Update: 2020-07-10
Although lung function tests (PFTs) are commonly used for screening ILD in Patients with SSc, studies have shown that PFTs are less sensitive to ILD in the general SSc queue.
Diffuse hyperplout nephroblastoma 1 case
Time of Update: 2020-06-25
Children and boys, 11 months and 17 days. Because of the discovery of painless abdominal swelling 1 week admission, no fever, blood urine and other discomfort. Physical examination: generally good condition, normal growth
Brit J Heamatol: Statins and epoxy 2 inhibitors improve survival in patients with diffuse large B cell lymphoma
Time of Update: 2020-06-24
, the use of statins and COX-2 inhibitors had dose-related survival benefits for patients prior to immunotherapy in newly diagnosed DLBCL patients.
NEJM: HLH-case reporting associated with diffuse TB
Time of Update: 2020-06-24
The patient was a 63-year-old man with chronic obstructive pulmonary disease (COPD) who went to the emergency department for fever, shortness of breath and confusion.
Pure natural black tofu made with constant temperature microbial fermentation point
Time of Update: 2020-06-21
> >, Zhengzhou well-known restaurant brand Banu belly hot pot launched a total of four new dishes, respectively, hydrangea, thick-cut beef, fennel oil strips and natural black tofu and other four.
Lancet oncol: Tafasitamab combined to the efficacy of nadoamine treatment for relapse/refractive diffuse large B cell lymphoma
Time of Update: 2020-06-16
Relapsed or refractive diffuse large B-cell lymphoma is not suitable for patients with self-contained stem cell transplantation with poor prognosis and few treatment options. Tafasitamab (MOR208) is a Fc-enhanced human-derived anti-CD19 monoclonal
FDA approves Roche Polivy combination therapy to treat relapsed patients with diffuse large B-cell lymphoma
Time of Update: 2020-06-09
recently, the United States The FDA ( approved Roche Polivy (formerly known as polatuzumab) in combination with rituxima and chemotherapy benzodiazepines for use in patients with diffuse
FDA approves gene tektronix antibody conjugate drug Polivy for treatment of incurable diffuse large B-cell lymphoma in adult patients
Time of Update: 2020-06-09
today, the United States The FDA ( announced the accelerated approval of gene tektronix's antibody conjugate drug ( Polatuzumab vedotin-piiq
2011 China Drug Expo offers constant online pre-registration that send three major gifts
Time of Update: 2020-06-04
Annex: invitation to the 2011 China Chinese Medicine Expo
Correlation factors of survival in patients with diffuse endogenous bridge glioma
Time of Update: 2020-06-03
compared to the STS group, children under 3 years of age and over 10 years of age were more common in the LTS group (11% vs.